Immune Oncology Biomarkers in Lung Cancer: an Overview
Sign Up to like & getrecommendations! Published in 2020 at "Current Oncology Reports"
DOI: 10.1007/s11912-020-00970-3
Abstract: Lung cancer is still the first cause of cancer-related deaths worldwide. The development of immune checkpoint inhibitors (ICI) has drastically changed the prognosis of some patients, but the rate of long responders does not exceed… read more here.
Keywords: biomarkers lung; oncology biomarkers; lung cancer; cancer ... See more keywords
The Challenge for Development of Valuable Immuno-oncology Biomarkers
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-16-3063
Abstract: The development of immunotherapy is an important breakthrough for the treatment of cancer, with antitumor efficacy observed in a wide variety of tumors. To optimize immunotherapy use, approaches must be developed to identify which patients… read more here.
Keywords: oncology biomarkers; challenge development; oncology; immuno oncology ... See more keywords
The 44th Congress of the International Society of Oncology and Biomarkers: Rio de Janeiro, Brazil, 7-10 September 2017.
Sign Up to like & getrecommendations! Published in 2018 at "Biomarkers in medicine"
DOI: 10.2217/bmm-2017-0402
Abstract: The 44th Congress of the International Society of Oncology and Biomarkers: Rio de Janeiro, Brazil, 7-10 September 2017 The 44th congress followed the previous one of International Society of Oncology and Biomarkers (ISOBM) that took… read more here.
Keywords: international society; society oncology; oncology biomarkers; 44th congress ... See more keywords